U
Uther
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Cagrilintide | A | 2 | 9.1 | 8.5 | 9.8 | 9 Oct 2025 |
| Mazdutide | A | 2 | 8.5 | 8.1 | 8.9 | 9 Oct 2025 |
| Melanotan II | A | 2 | 9.2 | 9.1 | 9.2 | 9 Oct 2025 |
| Semaglutide | A | 3 | 8.0 | 7.3 | 8.8 | 9 Oct 2025 |
| PT-141 | A | 2 | 9.8 | 9.7 | 10.0 | 9 Oct 2025 |
| Tesamorelin | A | 4 | 7.1 | 6.4 | 7.8 | 24 Jul 2025 |
| BPC-157 | C | 9 | 7.3 | 4.7 | 10.0 | 3 Jul 2025 |
| GHK-Cu | C | 6 | 7.3 | 4.2 | 9.5 | 9 Oct 2025 |
| Retatrutide | C | 13 | 7.3 | 4.7 | 10.0 | 3 Jul 2025 |
| Tirzepatide | C | 13 | 7.7 | 4.1 | 10.0 | 3 Jul 2025 |
| Ipamorelin | D | 5 | 7.4 | 3.3 | 10.0 | 9 Oct 2025 |
| Survodutide | D | 3 | 6.5 | 3.7 | 8.6 | 9 Oct 2025 |
| CJC-1295 | E | 5 | 5.8 | 0.0 | 10.0 | 9 Oct 2025 |
| 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | A | 4 | 7.8 | 5.7 | 10.0 | 26 Jan 2026 |
| 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | A | 5 | 7.5 | 5.4 | 10.0 | 26 Jan 2026 |
| Abaloparatide | A | 3 | 8.4 | 7.9 | 9.1 | 24 May 2026 |
| ACE-031 | A | 2 | 8.3 | 7.2 | 9.5 | 24 May 2026 |
| Anadrol Oil | A | 4 | 6.2 | 4.8 | 7.6 | 17 May 2026 |
| Andarine (S-4) Raw | X | 1 | 9.3 | 9.3 | 9.3 | 7 May 2025 |
| AOD9604 | A | 3 | 8.0 | 6.4 | 9.7 | 24 May 2026 |
| BAM15 | A | 6 | 7.2 | 6.0 | 9.6 | 24 May 2026 |
| Benzaldehyde CAS 100-52-7 | A | 5 | 9.0 | 7.2 | 10.0 | 24 May 2026 |
| BPC157 5mg + TB500 5mg Blend | A | 2 | 8.8 | 7.6 | 10.0 | 25 May 2026 |
| Cardiogen | A | 6 | 6.9 | 5.1 | 10.0 | 24 May 2026 |
| Chonluten | A | 2 | 8.0 | 7.0 | 9.0 | 24 May 2026 |
| CJC-1295 With DAC | A | 5 | 7.4 | 5.5 | 9.9 | 17 May 2026 |
| Dihexa | A | 4 | 6.8 | 5.2 | 8.2 | 23 May 2026 |
| DSIP | A | 3 | 8.3 | 6.9 | 9.9 | 23 May 2026 |
| Dutasteride | A | 6 | 8.7 | 6.7 | 10.0 | 21 May 2026 |
| EPO | A | 2 | 6.2 | 5.9 | 6.4 | 20 May 2026 |
| GHRP-2 Acetate | A | 6 | 7.0 | 5.6 | 10.0 | 20 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X | 1 | 6.6 | 6.6 | 6.6 | 13 Jun 2025 |
| Halotestin (Fluoxymesterone) | X | 1 | 7.3 | 7.3 | 7.3 | 11 Jun 2025 |
| LGD-4033 (Ligandrol) | A | 4 | 6.8 | 5.5 | 7.8 | 24 May 2026 |
| Nandrolone Decanoate (Deca) Raw | A | 2 | 8.4 | 8.4 | 8.4 | 23 May 2026 |
| NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | A | 6 | 7.2 | 4.3 | 10.0 | 19 Jan 2026 |
| Oxytocin Acetate | A | 3 | 5.8 | 4.5 | 6.6 | 17 May 2026 |
| Pinealon | A | 2 | 9.3 | 8.7 | 10.0 | 24 May 2026 |
| Primobolan E Raw | X | 1 | 8.7 | 8.7 | 8.7 | 20 Jun 2025 |
| Primobolan Oral (Methenolone Acetate) | A | 3 | 8.2 | 7.6 | 9.2 | 20 May 2026 |
| PTD-DBM | A | 5 | 8.1 | 5.7 | 9.5 | 23 May 2026 |
| Retatrutide 30mg Pen Kit | A | 3 | 8.3 | 7.2 | 9.8 | 21 May 2026 |
| Selank | A | 4 | 8.1 | 6.0 | 10.0 | 25 May 2026 |
| Semaglutide Raw | A | 6 | 6.2 | 4.5 | 8.1 | 26 Jan 2026 |
| SLU-PP-332 | A | 3 | 7.5 | 6.7 | 8.0 | 19 Jan 2026 |
| Sustanon 250 | A | 3 | 7.2 | 5.3 | 9.4 | 17 May 2026 |
| Tamoxifen (Nolvadex) | A | 4 | 7.6 | 6.3 | 8.7 | 21 May 2026 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | A | 5 | 6.7 | 2.4 | 9.5 | 21 May 2026 |
| Thymalin | A | 5 | 6.7 | 5.0 | 8.3 | 21 May 2026 |
| Trenbolone Acetate | A | 3 | 7.2 | 5.5 | 8.9 | 17 May 2026 |
| Turinabol Raw | A | 5 | 6.0 | 4.2 | 7.6 | 23 May 2026 |
| Winstrol Oil (Stanozolol) | X | 1 | 8.2 | 8.2 | 8.2 | 3 Jul 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | CJC-1295 | NO DAC | 10.0 | 10mg | 9.6mg | -4.0% | Silver Label / Black Crimp / Clear Red Cap |
| 25 May 2026 | Abaloparatide | 9.1 | 10mg | 8.9mg | -11.0% | 99.44% | Lab E |
| 25 May 2026 | BAM15 | 7.8 | 100mg | 111.4mg | +11.4% | 96.92% | Lab A |
| 25 May 2026 | Cardiogen | 9.6 | 20mg | 18.8mg | -5.9% | 95.81% | Lab E |
| 25 May 2026 | Dihexa | 6.1 | 50mg | 55.7mg | +11.4% | 98.74% | Lab G |
| 25 May 2026 | Primobolan E Raw | 8.3 | 1g | 1.2g | +20.4% | 97.09% | Lab D |
| 24 May 2026 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 8.7 | 5g | 4.8g | -3.2% | 99.38% | Lab C |
| 24 May 2026 | Andarine (S-4) Raw | 9.6 | 5g | 5.6g | +12.1% | 97.06% | Lab B |
| 24 May 2026 | Semaglutide Raw | 4.5 | 1g | 0.9g | -10.8% | 97.56% | Lab B |
| 24 May 2026 | GHK-Cu | 4.2 | 50mg | 27.7mg | -44.6% | No Label / Silver Crimp / White Cap | |
| 24 May 2026 | Retatrutide | 7.3 | 10mg | 10mg | No Label / Silver Crimp / Clear Blue Cap | ||
| 24 May 2026 | Retatrutide | 6.4 | 5mg | 5.2mg | +4.0% | No Label / Silver Crimp / Clear Cap | |
| 24 May 2026 | Thymalin | 6.2 | 15mg | 14.1mg | -5.7% | 96.23% | Lab F |
| 24 May 2026 | Turinabol Raw | 7.1 | 500g | 427.3g | -14.5% | 97.03% | Lab A |
| 24 May 2026 | AOD9604 | 8.3 | 2mg | 1.9mg | -6.9% | 97.57% | Lab D |
| 24 May 2026 | Dihexa | 7.3 | 50mg | 45.2mg | -9.7% | 95.42% | Lab E |
| 24 May 2026 | Halotestin (Fluoxymesterone) | 8.1 | 25mg | 21.4mg | -14.3% | 97.43% | Lab C |
| 24 May 2026 | PTD-DBM | 7.8 | 2mg | 2.0mg | -0.8% | 95.56% | Lab F |
| 24 May 2026 | Cardiogen | 4.0 | 5mg | 4.8mg | -4.3% | 96.56% | Lab F |
| 24 May 2026 | DSIP | 9.4 | 2mg | 2.4mg | +20.7% | 96.13% | Lab C |
| 24 May 2026 | Selank | 7.8 | 30mg | 26.2mg | -12.8% | 97.37% | Lab B |
| 24 May 2026 | Retatrutide | 8.2 | 30mg | 33.1mg | +10.3% | No Label / Green Crimp / Green Cap | |
| 24 May 2026 | Benzaldehyde CAS 100-52-7 | 10.0 | 500g | 482.3g | -3.5% | 96.27% | Lab D |
| 24 May 2026 | DSIP | 8.6 | 30mg | 35.3mg | +17.8% | 97.94% | Lab B |
| 24 May 2026 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 8.1 | 1g | 1.0g | -0.8% | 97.05% | Lab F |
| 24 May 2026 | Oxytocin Acetate | 5.8 | 30mg | 33.4mg | +11.2% | 97.98% | Lab C |
| 24 May 2026 | Selank | 7.5 | 20mg | 22.6mg | +12.9% | 95.05% | Lab F |
| 24 May 2026 | Semaglutide Raw | 5.4 | 1g | 1.2g | +21.0% | 98.86% | Lab C |
| 24 May 2026 | Thymalin | 8.1 | 2mg | 1.7mg | -14.4% | 98.02% | Lab G |
| 23 May 2026 | CJC-1295 | NO DAC | 0.0 | 5mg | ⚠️ Sample does not contain CJC-1295 (NO DAC)? | (no batch ID) | Public |
| 23 May 2026 | Cardiogen | 6.2 | 50mg | 54.6mg | +9.2% | 99.49% | Lab D |
| 23 May 2026 | GHRP-2 Acetate | 4.8 | 50mg | 42.8mg | -14.5% | 99.97% | Lab B |
| 23 May 2026 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 5.7 | 10g | 10.9g | +8.7% | 95.03% | Lab B |
| 23 May 2026 | Primobolan Oral (Methenolone Acetate) | 9.0 | 20mg | 21.3mg | +6.7% | 98.36% | Lab A |
| 23 May 2026 | Primobolan Oral (Methenolone Acetate) | 8.2 | 25mg | 26.9mg | +7.7% | 96.27% | Lab A |
| 23 May 2026 | 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | 8.1 | 10g | 9.9g | -1.2% | 95.64% | Lab F |
| 23 May 2026 | Anadrol Oil | 5.9 | 250mg/ml | 246.9mg/ml | -1.2% | 96.19% | Lab B |
| 23 May 2026 | BAM15 | 6.8 | 50mg | 57.0mg | +14.1% | 95.03% | Lab C |
| 23 May 2026 | CJC-1295 With DAC | 5.8 | 50mg | 52.9mg | +5.8% | 96.51% | Lab E |
| 23 May 2026 | Primobolan Oral (Methenolone Acetate) | 8.8 | 100mg | 120.0mg | +20.0% | 99.86% | Lab A |
| 23 May 2026 | PTD-DBM | 4.3 | 50mg | 47.7mg | -4.5% | 98.77% | Lab G |
| 21 May 2026 | BPC-157 | 10.0 | 20mg | 19.2mg | -4.0% | White Label / Black Crimp / Green Cap | |
| 21 May 2026 | Benzaldehyde CAS 100-52-7 | 9.0 | 10g | 12.1g | +20.9% | 95.24% | Lab F |
| 21 May 2026 | Chonluten | 8.3 | 15mg | 13.2mg | -12.2% | 97.62% | Lab E |
| 21 May 2026 | CJC-1295 With DAC | 6.2 | 5mg | 5.6mg | +12.5% | 97.83% | Lab C |
| 21 May 2026 | Dutasteride | 7.3 | 100mg | 109.2mg | +9.2% | 95.44% | Lab A |
| 21 May 2026 | LGD-4033 (Ligandrol) | 8.0 | 10mg | 11.8mg | +17.6% | 99.60% | Lab C |
| 21 May 2026 | Pinealon | 10.0 | 10mg | 9.4mg | -6.0% | 97.73% | Lab A |
| 20 May 2026 | Anadrol Oil | 7.8 | 300mg/ml | 296.2mg/ml | -1.3% | 96.58% | Lab C |
| 20 May 2026 | BAM15 | 6.0 | 10mg | 11.0mg | +9.8% | 97.10% | Lab A |
| 20 May 2026 | Dutasteride | 8.7 | 25mg | 27.3mg | +9.2% | 95.56% | Lab E |
| 20 May 2026 | Dutasteride | 8.7 | 100mg | 100.3mg | +0.3% | 99.61% | Lab B |
| 20 May 2026 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 7.9 | 5g | 4.7g | -5.4% | 97.36% | Lab E |
| 20 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.4 | 30mg | 36.3mg | +21.1% | 95.23% | Lab E |
| 19 May 2026 | Benzaldehyde CAS 100-52-7 | 9.4 | 5g | 6.0g | +20.9% | 99.51% | Lab E |
| 19 May 2026 | PTD-DBM | 9.1 | 5mg | 5.4mg | +7.7% | 98.98% | Lab D |
| 19 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.8 | 20mg | 23.4mg | +16.8% | 99.93% | Lab G |
| 17 May 2026 | AOD9604 | 8.2 | 10mg | 10.1mg | +1.4% | 95.71% | Lab A |
| 17 May 2026 | Chonluten | 7.7 | 30mg | 33.6mg | +12.1% | 96.30% | Lab E |
| 17 May 2026 | CJC-1295 With DAC | 8.0 | 20mg | 19.4mg | -3.0% | 95.46% | Lab A |
| 17 May 2026 | Dutasteride | 8.1 | 100mg | 106.2mg | +6.2% | 99.80% | Lab C |
| 17 May 2026 | Pinealon | 8.0 | 10mg | 9.8mg | -2.1% | 98.53% | Lab G |
| 17 May 2026 | Tamoxifen (Nolvadex) | 9.6 | 10mg | 9.8mg | -2.5% | 96.98% | Lab G |
| 17 May 2026 | Tamoxifen (Nolvadex) | 7.3 | 10mg | 9.6mg | -4.2% | 98.28% | Lab G |
| 17 May 2026 | Turinabol Raw | 5.7 | 100g | 103.2g | +3.2% | 98.77% | Lab F |
| 29 Jan 2026 | GHRP-2 Acetate | 8.4 | 2mg | 2.1mg | +6.9% | 99.11% | Lab E |
| 29 Jan 2026 | LGD-4033 (Ligandrol) | 5.9 | 100mg | 85.0mg | -15.0% | 96.47% | Lab F |
| 26 Jan 2026 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 7.3 | 500g | 582.0g | +16.4% | 95.97% | Lab A |
| 26 Jan 2026 | Oxytocin Acetate | 4.7 | 20mg | 19.9mg | -0.6% | 99.15% | Lab G |
| 26 Jan 2026 | Turinabol Raw | 6.2 | 5g | 4.3g | -14.4% | 96.03% | Lab C |
| 19 Jan 2026 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 7.3 | 10g | 11.0g | +9.6% | 98.26% | Lab B |
| 19 Jan 2026 | BPC157 5mg + TB500 5mg Blend | 7.6 | 50mg | 56.6mg | +13.3% | 95.88% | Lab F |
| 19 Jan 2026 | CJC-1295 With DAC | 8.3 | 15mg | 13.6mg | -9.1% | 95.07% | Lab D |
| 19 Jan 2026 | Dihexa | 7.5 | 10mg | 12.2mg | +21.6% | 99.85% | Lab G |
| 19 Jan 2026 | Selank | 7.7 | 10mg | 9.4mg | -5.5% | 97.86% | Lab B |
| 9 Jan 2026 | BAM15 | 9.1 | 10mg | 10.4mg | +4.5% | 97.17% | Lab B |
| 9 Jan 2026 | Cardiogen | 6.4 | 10mg | 12.5mg | +24.9% | 95.61% | Lab B |
| 9 Jan 2026 | GHRP-2 Acetate | 7.9 | 30mg | 26.4mg | -12.0% | 96.10% | Lab D |
| 7 Jan 2026 | 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | 8.6 | 500g | 609.1g | +21.8% | 98.99% | Lab C |
| 7 Jan 2026 | ACE-031 | 8.5 | 5mg | 4.7mg | -5.4% | 98.63% | Lab C |
| 7 Jan 2026 | Anadrol Oil | 6.0 | 300mg/ml | 257.8mg/ml | -14.1% | 98.24% | Lab A |
| 7 Jan 2026 | Benzaldehyde CAS 100-52-7 | 10.0 | 10g | 11.6g | +15.8% | 97.08% | Lab B |
| 7 Jan 2026 | GHRP-2 Acetate | 6.3 | 15mg | 15.1mg | +0.4% | 97.28% | Lab A |
| 7 Jan 2026 | Semaglutide Raw | 5.1 | 100g | 93.7g | -6.3% | 95.02% | Lab B |
| 7 Jan 2026 | Tamoxifen (Nolvadex) | 7.3 | 100mg | 116.0mg | +16.0% | 97.18% | Lab E |
| 7 Jan 2026 | Tamoxifen (Nolvadex) | 9.0 | 10mg | 11.6mg | +16.1% | 97.18% | Lab A |
| 7 Jan 2026 | Trenbolone Acetate | 8.2 | 100mg/ml | 104.8mg/ml | +4.8% | 97.92% | Lab A |
| 6 Jan 2026 | LGD-4033 (Ligandrol) | 6.3 | 100mg | 118.0mg | +18.0% | 97.86% | Lab B |
| 6 Jan 2026 | Retatrutide 30mg Pen Kit | 8.3 | 10mg | 12.4mg | +24.1% | 98.25% | Lab E |
| 29 Dec 2025 | Abaloparatide | 7.7 | 15mg | 17.2mg | +14.6% | 99.06% | Lab C |
| 29 Dec 2025 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 6.3 | 5g | 5.5g | +9.5% | 97.35% | Lab D |
| 29 Dec 2025 | PTD-DBM | 7.1 | 20mg | 22.2mg | +11.1% | 95.51% | Lab A |
| 29 Dec 2025 | SLU-PP-332 | 6.7 | 20mg | 22.3mg | +11.3% | 99.50% | Lab C |
| 29 Dec 2025 | SLU-PP-332 | 9.1 | 20mg | 21.1mg | +5.5% | 95.14% | Lab E |
| 29 Dec 2025 | Trenbolone Acetate | 7.1 | 100mg/ml | 123.4mg/ml | +23.4% | 98.82% | Lab A |
| 12 Dec 2025 | SLU-PP-332 | 6.3 | 25mg | 27.6mg | +10.2% | 97.41% | Lab A |
| 12 Dec 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 7.4 | 30mg | 31.3mg | +4.5% | 95.09% | Lab E |
| 5 Dec 2025 | 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | 7.9 | 5g | 5.9g | +17.0% | 97.78% | Lab A |
| 5 Dec 2025 | GHRP-2 Acetate | 6.8 | 10mg | 9.4mg | -5.5% | 98.26% | Lab F |
| 5 Dec 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 8.4 | 2mg | 2.1mg | +6.7% | 96.04% | Lab B |
| 5 Dec 2025 | LGD-4033 (Ligandrol) | 5.8 | 20mg | 24.7mg | +23.6% | 98.94% | Lab C |
| 5 Dec 2025 | Sustanon 250 | 8.0 | 200mg/ml | 179.9mg/ml | -10.1% | 97.86% | Lab B |
| 5 Dec 2025 | Thymalin | 6.7 | 15mg | 16.3mg | +8.6% | 96.26% | Lab G |
| 5 Dec 2025 | Trenbolone Acetate | 8.1 | 100mg/ml | 123.1mg/ml | +23.1% | 98.34% | Lab G |
| 23 Nov 2025 | Dihexa | 5.6 | 50mg | 50.7mg | +1.3% | 98.30% | Lab D |
| 23 Nov 2025 | GHRP-2 Acetate | 7.9 | 10mg | 9.6mg | -3.7% | 95.04% | Lab G |
| 23 Nov 2025 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 6.1 | 5g | 6.1g | +21.3% | 98.45% | Lab D |
| 23 Nov 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 8.5 | 20mg | 19.3mg | -3.3% | 96.89% | Lab F |
| 23 Nov 2025 | Turinabol Raw | 5.6 | 100g | 120.0g | +20.0% | 96.07% | Lab A |
| 17 Nov 2025 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 6.5 | 1g | 1.0g | +1.1% | 96.65% | Lab C |
| 17 Nov 2025 | 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | 7.5 | 500g | 520.2g | +4.0% | 95.65% | Lab C |
| 17 Nov 2025 | BPC157 5mg + TB500 5mg Blend | 10.0 | 10mg | 12.2mg | +21.9% | 96.55% | Lab C |
| 17 Nov 2025 | Cardiogen | 7.5 | 30mg | 31.0mg | +3.4% | 98.65% | Lab D |
| 17 Nov 2025 | Nandrolone Decanoate (Deca) Raw | 7.6 | 1g | 1.0g | -2.9% | 96.33% | Lab C |
| 17 Nov 2025 | Selank | 8.6 | 2mg | 2.1mg | +5.9% | 97.02% | Lab E |
| 14 Nov 2025 | Anadrol Oil | 5.9 | 300mg/ml | 296.5mg/ml | -1.2% | 96.83% | Lab C |
| 14 Nov 2025 | BAM15 | 7.7 | 100mg | 121.7mg | +21.7% | 99.91% | Lab A |
| 14 Nov 2025 | Oxytocin Acetate | 5.2 | 50mg | 56.5mg | +13.0% | 96.74% | Lab A |
| 5 Nov 2025 | Benzaldehyde CAS 100-52-7 | 9.7 | 1g | 1.0g | +1.3% | 97.21% | Lab F |
| 5 Nov 2025 | DSIP | 7.5 | 2mg | 2.1mg | +5.0% | 98.91% | Lab C |
| 5 Nov 2025 | Nandrolone Decanoate (Deca) Raw | 9.3 | 500g | 493.6g | -1.3% | 99.43% | Lab A |
| 5 Nov 2025 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 6.0 | 5g | 5.7g | +13.9% | 95.67% | Lab C |
| 5 Nov 2025 | PTD-DBM | 10.0 | 5mg | 4.8mg | -4.7% | 98.20% | Lab G |
| 5 Nov 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.5 | 20mg | 17.2mg | -13.9% | 99.85% | Lab D |
| 5 Nov 2025 | Turinabol Raw | 4.0 | 5g | 6.1g | +22.2% | 97.34% | Lab E |
| 5 Nov 2025 | Winstrol Oil (Stanozolol) | 7.3 | 100mg/ml | 121.0mg/ml | +21.0% | 99.32% | Lab D |
| 4 Nov 2025 | ACE-031 | 8.7 | 2mg | 2.0mg | +2.0% | 96.02% | Lab F |
| 4 Nov 2025 | BAM15 | 4.6 | 50mg | 53.7mg | +7.4% | 97.40% | Lab F |
| 4 Nov 2025 | Semaglutide Raw | 5.9 | 100g | 114.5g | +14.5% | 97.98% | Lab E |
| 4 Nov 2025 | Semaglutide Raw | 8.4 | 10g | 12.2g | +22.4% | 98.30% | Lab C |
| 17 Oct 2025 | Abaloparatide | 10.0 | 30mg | 26.3mg | -12.4% | 95.73% | Lab E |
| 17 Oct 2025 | Cardiogen | 7.1 | 2mg | 1.8mg | -9.0% | 99.91% | Lab B |
| 17 Oct 2025 | CJC-1295 With DAC | 8.7 | 30mg | 33.1mg | +10.5% | 97.45% | Lab F |
| 17 Oct 2025 | Sustanon 250 | 7.3 | 200mg/ml | 249.3mg/ml | +24.7% | 97.61% | Lab E |
| 17 Oct 2025 | Thymalin | 4.1 | 20mg | 20.0mg | -0.1% | 98.29% | Lab A |
| 9 Oct 2025 | Dutasteride | 7.5 | 25mg | 26.7mg | +6.9% | 99.35% | Lab B |
| 9 Oct 2025 | Retatrutide 30mg Pen Kit | 7.6 | 2mg | 2.3mg | +16.0% | 95.43% | Lab G |
| 9 Oct 2025 | Semaglutide Raw | 6.5 | 1g | 0.9g | -11.2% | 99.84% | Lab G |
| 9 Oct 2025 | Sustanon 250 | 8.6 | 300mg/ml | 279.0mg/ml | -7.0% | 96.71% | Lab C |
| 9 Oct 2025 | Thymalin | 5.7 | 30mg | 33.7mg | +12.2% | 97.09% | Lab A |
| 3 Oct 2025 | 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | 7.2 | 1g | 1.2g | +22.0% | 99.40% | Lab C |
| 3 Oct 2025 | AOD9604 | 7.7 | 15mg | 15.5mg | +3.5% | 97.13% | Lab D |
| 3 Oct 2025 | Dutasteride | 7.8 | 25mg | 22.2mg | -11.1% | 99.98% | Lab D |
| 3 Oct 2025 | EPO | 7.1 | 5mg | 4.7mg | -5.5% | 99.61% | Lab F |
| 3 Oct 2025 | EPO | 8.0 | 50mg | 45.4mg | -9.2% | 98.38% | Lab C |
| 3 Oct 2025 | Retatrutide 30mg Pen Kit | 7.5 | 10mg | 8.7mg | -12.9% | 95.00% | Lab F |